David W. Rusnak
- Oncology top 1%
- Molecular Biology top 5%
- Radiology, Nuclear Medicine and Imaging top 1%
- Pulmonary and Respiratory Medicine top 2%
- Organic Chemistry top 5%
- Co-authors
- Krystal J. AlligoodTona M. GilmerRobert J. MullinBarry R. KeithEdgar R. WoodKaren LackeyScott H. DickersonLisa M. Shewchuk
- Topics
- HER2/EGFR in Cancer Research (14 papers)Monoclonal and Polyclonal Antibodies Research (7 papers)Chronic Lymphocytic Leukemia Research (6 papers)
- Journals
- BloodCancer ResearchOncogene
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
David W. Rusnak
24 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 2.3k
- Molecular Biology 1.4k
- Radiology, Nuclear Medicine and Imaging 947
- Pulmonary and Respiratory Medicine 882
- Organic Chemistry 595
Countries citing papers authored by David W. Rusnak
This map shows the geographic impact of David W. Rusnak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Rusnak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Rusnak more than expected).
Fields of papers citing papers by David W. Rusnak
This network shows the impact of papers produced by David W. Rusnak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Rusnak. The network helps show where David W. Rusnak may publish in the future.
Co-authorship network of co-authors of David W. Rusnak
This figure shows the co-authorship network connecting the top 25 collaborators of David W. Rusnak. A scholar is included among the top collaborators of David W. Rusnak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Rusnak. David W. Rusnak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 0 | |
| 4 | 33 | |
| 5 | 18 | |
| 6 | 51 | |
| 7 | 72 | |
| 8 | 29 | |
| 9 | 149 | |
| 10 | 144 | |
| 11 | A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)breakdown → | 881 |
| 12 | 12 | |
| 13 | 40 | |
| 14 | Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathwaysbreakdown → | 548 |
| 15 | The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo.breakdown → | 590 |
| 16 | 13 | |
| 17 | 9 | |
| 18 | 8 | |
| 19 | 20 | |
| 20 | 16 |
About David W. Rusnak
David W. Rusnak is a scholar working on Oncology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 25 papers that have together received 3.5k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (14 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Oncology (2.3k citations), Radiology, Nuclear Medicine and Imaging (947 citations) and Genetics (424 citations). David W. Rusnak has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Krystal J. Alligood, Tona M. Gilmer, Robert J. Mullin, Barry R. Keith, Edgar R. Wood, Karen Lackey, Scott H. Dickerson, Lisa M. Shewchuk, Glenn Spehar and Anne T. Truesdale. Their work appears in journals such as Blood, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.